Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models

Author：                          

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.30, Iss.2, 2013-01, pp. : 707-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinoma

By                              

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 785-792

Spandidos Publications

Access to resources Recommend Favorite

Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases

By                

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 583-588

Spandidos Publications

Access to resources Recommend Favorite

Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma

By Sugawara Mitsuhiro  

Esophagus, Vol. 10, Iss. 2, 2013-06 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma

By  

JOURNAL OF CELLULAR BIOCHEMISTRY, Vol. 119, Iss. 2, 2018-02 ,pp. : 2231-2239

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin

By Minegaki Tetsuya   Takara Kohji   Hamaguchi Ryohei   Tsujimoto Masayuki   Nishiguchi Kohshi  

Oncology Letters, Vol. 5, Iss. 2, 2013-02 ,pp. : 427-434

Spandidos Publications

Access to resources Recommend Favorite